Pilot study shows suppression of mineralocorticoid precursors under high-dose glucocorticoid therapy in pediatric acute lymphoblastic leukemia
Open Access
- 31 July 2023
- journal article
- research article
- Published by Bioscientifica in Endocrine Connections
- Vol. 12 (10)
Abstract
Glucocorticoids represent a key element in the treatment of pediatric acute lymphoblastic leukemia (ALL) and lead to adrenal suppression. We aimed to assess the differential response profile of adrenal steroids in children with ALL during BFM (Berlin-Frankfurt-Münster) induction treatment. Therefore, we performed LC-MS/MS-based steroid profiling of up to 7 consecutive left-over morning serum samples derived from 11 patients (pts) with ALL before (day 0) and during induction therapy at days 1-5, 6-12, 13-26, 27-29, 30-35 and 36-40. 17-hydroxyprogesterone (17OHP), 11-deoxycortisol (11S), cortisol, 11-deoxycorticosterone (DOC), corticosterone and aldosterone were determined in parallel. Subsequently, steroid concentrations were normalized by multiples of median (MOM) to adequately consider pediatric age- and sex-specific reference ranges. MOM-cortisol and its precursors MOM-11S and MOM-17OHP were significantly suppressed by glucocorticoid treatment until day 29 (p<8.06 x10-10, p<5.102x10-5, p<0.0076, respectively). Cortisol recovered in 1 of 4 pts at days 27-29 and in 2 of 5 pts at days 36-40. Among the mineralocorticoids, corticosterone was significantly suppressed (p<3.115x10-6). Aldosterone and DOC showed no significant changes when comparing day 0 to the treatment time points. However, 2 ALL-patients with ICU treatment due to sepsis showed significantly lower MOM-DOC (p = 0.006436) during that time and almost always the lowest aldosterone compared to all other time points. Suppression of mineralocorticod precursors under high dose glucocorticoid therapy suggests a functional crosstalk of central glucocorticoid regulation and adrenal mineralocorticoid synthesis. Our data should stimulate prospective investigation to assess potential clinical relevance.Keywords
This publication has 27 references indexed in Scilit:
- Evaluation of Adrenal Reserve in Children with Acute Lymphocytic Leukemia Treated with Prednisone or DexamethasoneHormone Research in Paediatrics, 2012
- A Case of 11β-Hydroxylase Deficiency Detected in a Newborn Screening Program by Second-Tier LC-MS/MSHormone Research in Paediatrics, 2008
- Adrenal axis function after high‐dose steroid therapy for childhood acute lymphoblastic leukemiaPediatric Blood & Cancer, 2008
- Congenital adrenal hyperplasia and P450 oxidoreductase deficiencyClinical Endocrinology, 2006
- Clinical Impact of Corticosteroid-Induced Adrenal Suppression during Treatment for Acute Lymphoblastic Leukemia in Children: A Prospective Observational Study Using the Low-Dose Adrenocorticotropin TestThe Journal of Pediatrics, 2005
- Suppression of adrenal function in children with acute lymphoblastic leukemia following induction therapy with corticosteroid and other cytotoxic agentsThe Journal of Pediatrics, 2004
- Impaired adrenal function after glucocorticoid therapy in children with acute lymphoblastic leukemiaMedical and Pediatric Oncology, 2003
- Time course of recovery of adrenal function in children treated for leukemiaThe Journal of Pediatrics, 2000
- Evaluation of the Dexamethasone Suppression Test for the Diagnosis of Glucocorticoid-Remediable Aldosteronism1The Journal of Clinical Endocrinology & Metabolism, 1997
- Dissociation of plasma renin activity and plasma aldosterone level during dexamethasone suppression test in non-salt-losers with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.Endocrinologia Japonica, 1980